Christopher T Ritchlin

53PUBLICATIONS

119CO-AUTHORS

Tissue engineeringRheumatology and arthritisPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tribology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (53)

Sort by Publication Date:

|Jun 15, 2026

Synovial Telocytes are Characterized by Efhd1, Dpp4, and Pi16 Expression, Show High Responsiveness to Osmotic Stress, and Exhibit Fibroblast Plasticity Potential.

|May 05, 2026

Effects of Guselkumab on Structural Damage Progression in Patients with Active Psoriatic Arthritis.

|Mar 25, 2026

Combination Therapy in Participants With Active Psoriatic Arthritis Using Subcutaneous Guselkumab and Golimumab: Week 24 Results From a Phase 2a, Multicenter, Randomized, Double-Blind, Proof-of-Concept Study.

Jose U Scher, Iain B McInnes, Enrique R Soriano

|Mar 16, 2026

Bimekizumab safety and efficacy in patients with psoriatic arthritis: 3-year results from two phase 3 studies.

Laure Gossec, Laura C Coates, Robert B M Landewé

|Mar 16, 2026

Telocyte Deletion Associated With Loss of Lymphatic Drainage and Exacerbation of Inflammatory-Erosive Arthritis in Mice.

Yue Peng, H Mark Kenney, Sean Lydon

|Feb 11, 2026

Efficacy and Safety of Guselkumab in Participants With Active Psoriatic Arthritis After Inadequate Response to One Prior Tumor Necrosis Factor Inhibitor: Week-24 Results of a Phase 3, Randomized, Placebo-Controlled Study.

Alexis Ogdie, Joseph F Merola, Philip J Mease

Pageof 9

Frequent Collaborators

20 joint publications

Phillip J Mease

11 joint publications

Laura C Coates

Alexis Ogdie

Oliver FitzGerald

Philip S Helliwell

Iain B McInnes

Jose U Scher

Stephen R Pennington

Soumya D Chakravarty

Dafna D Gladman

Frequent Collaborators

20 joint publications

Phillip J Mease

11 joint publications

Laura C Coates

9 joint publications

Alexis Ogdie

9 joint publications

Oliver FitzGerald